A. Beretta

发表

Expression of CD4 on human peripheral blood neutrophils.

A. Lazzarin, A. Sica, A. Saccani, 2003, Blood.

The appealing story of HIV entry inhibitors : from discovery of biological mechanisms to drug development.

A. Lazzarin, P. Biswas, A. Castagna, 2005, Drugs.

Adacolumn for selective leukocytapheresis as a non‐pharmacological treatment for patients with disorders of the immune system: An adjunct or an alternative to drug therapy?

I. Bjarnason, T. Ohmori, M. Nakashima, 2005, Journal of clinical apheresis.

Human immunodeficiency virus type 1 glycoprotein 120-specific T lymphocytes provide intermolecular help for anti-CD4 autoantibody production in exposed uninfected subjects.

L. Lopalco, A. Lazzarin, S. Burastero, 1997, AIDS research and human retroviruses.

HLA-C increases HIV-1 infectivity and is associated with gp120

A. Siccardi, A. Matucci, D. Zipeto, 2008, Retrovirology.

Serology study after BTN162b2 vaccination in participants previously infected with SARS-CoV-2 in two different waves versus naïve

L. Lopalco, M. Valenti, L. Dalle Carbonare, 2021, Communications Medicine.

Human immunodeficiency virus type 1 gp120 C5 region mimics the HLA class I α1 peptide‐binding domain

L. Lopalco, R. Longhi, R. Meneveri, 1993, European journal of immunology.

Stability and Expression Levels of HLA-C on the Cell Membrane Modulate HIV-1 Infectivity

M. Scupoli, R. Biassoni, M. Romanelli, 2017, Journal of Virology.

HLA-C and HIV-1: friends or foes?

D. Zipeto, A. Beretta, 2012, Retrovirology.

SARS-CoV-2 vaccination elicits unconventional IgM specific responses in naïve and previously COVID-19-infected individuals

L. Lopalco, N. Temperton, S. Accordini, 2022, EBioMedicine.

R 5-Tropic Strains of HIV-1 Macrophages and Lymphocytes with Primary Normal Human IgG Block Infection of Antibodies to C-C Chemokine Receptor 5 in Kaveri and

S. Kaveri, M. Kazatchkine, R. Longhi, 2001 .

HLA-C heavy chains free of ß2-microglobulin: distribution in normal tissues and neoplastic lesions of non-lymphoid origin and interferon-γ responsiveness

L. Lopalco, G. Ferrara, A. Martayan, 1997 .

Role of HLA class I in HIV type 1-induced syncytium formation.

R. Longhi, A. Siccardi, A. Beretta, 1996, AIDS research and human retroviruses.

Distinctive features of the alpha 1-domain alpha helix of HLA-C heavy chains free of beta 2-microglobulin.

E. Appella, M. Mazzilli, A. Martayan, 1996, Human Immunology.

Evidence for the expression of HLAA-C class I mRNA and protein by human first trimester trophoblast.

A. Sharkey, A. Siccardi, L. Gardner, 1996, Journal of immunology.

Human antibodies to immunodominant C5 region of HIV-1 gp120 cross-react with HLA class I on activated cells.

L. Lopalco, R. Longhi, A. Siccardi, 1994, AIDS research and human retroviruses.

Expression of β2m‐Free HLA Class I Heavy Chains in Neuroblastoma Cell Lines

L. Lopalco, G. D. Valle, A. Agresti, 1993 .

Requirement for the Involvement of Clonally Distributed Receptors in the Activation of Cytotoxic T Lymphocytes

A. Coutinho, M. Gullberg, E. Larsson, 1982, Immunological reviews.

General role of HLA class I molecules in the protection of target cells from lysis by natural killer cells: evidence that the free heavy chains of class I molecules are not sufficient to mediate the protective effect.

E. Ciccone, L. Moretta, A. Moretta, 1995, International immunology.

Conformation and surface expression of free HLA-CW1 heavy chains in the absence of beta 2-microglobulin.

M. Fiscella, E. Appella, R. Gambari, 1997, Human immunology.

Antibody response to BTN162b2 mRNA vaccination in naïve versus SARS-CoV-2 infected subjects with and without waning immunity

L. Lopalco, M. Valenti, C. Piubelli, 2021 .

Human immunodeficiency virus type 1 (HIV-1)-seronegative injection drug users at risk for HIV exposure have antibodies to HLA class I antigens and T cells specific for HIV envelope.

J. Berzofsky, G. Shearer, A. Cosma, 1996, The Journal of infectious diseases.

Ionophore A23-187 induces responses to TCGF in mouse lymphocytes.

M. Gullberg, E. Larsson, G. Möller, 1984, Annales d'immunologie.

The Cytotoxic T‐Cell Response to la Antigens: Lack of Correlation between the Level of Specific Cytotoxicity Obtained in Primary Mixed Lymphocyte Reaction and the Frequency of Specific Cytotoxic T Lymphocyte

E. Larsson, P. Demoyen, A. Beretta, 1986, Scandinavian journal of immunology.

In vivo modulation of leukocyte trafficking receptor following therapeutic purging of myeloid cells: implications for treatment of HIV infection and other immune disorders.

A. Lazzarin, P. Biswas, B. Mantelli, 2003, Clinical immunology.

HIV-1-specific immunity in persistently seronegative individuals at high risk for HIV infection.

L. Lopalco, A. Lazzarin, M. Clerici, 1996, Immunology letters.

Concanavalin A Inhibits the Effector Phase of Specific Cytotoxicity

U. Persson, G. Möller, A. Beretta, 1982, Scandinavian journal of immunology.

Anti-HIV type 1 properties of chemically modified heparins with diminished anticoagulant activity.

L. Lopalco, A. Siccardi, F. Leoni, 1994, AIDS research and human retroviruses.

Enhanced HIV infectivity and changes in GP120 conformation associated with viral incorporation of human leucocyte antigen class I molecules.

B. Spire, C. Moog, A. Siccardi, 1999, AIDS.

Antibodies to C-C Chemokine Receptor 5 in Normal Human IgG Block Infection of Macrophages and Lymphocytes with Primary R5-Tropic Strains of HIV-11

S. Kaveri, M. Kazatchkine, R. Longhi, 2001, The Journal of Immunology.

HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene

Luc Montagnier, Dominique Rousset, L. Montagnier, 1998, The Lancet.

Antigen-driven C–C Chemokine-mediated HIV-1 Suppression by CD4+ T Cells from Exposed Uninfected Individuals Expressing the Wild-type CCR-5 Allele

A. Lazzarin, R. Longhi, S. Burastero, 1997, The Journal of experimental medicine.

Degeneracy of H‐2 recognition by cytotoxic T lymphocytes: 10% of the total repertoire is “specific” for a given haplotype and up to 1% is self‐H‐2 reactive

M. Ermonval, E. Larsson, A. Beretta, 1986, European journal of immunology.

HIV env glycoprotein shares a cross‐reacting epitope with a surface protein present on activated human monocytes and involved in antigen presentation

L. Lopalco, G. Giovinazzo, S. Buttò, 1987, European journal of immunology.

HIV-1 Env associates with HLA-C free-chains at the cell membrane modulating viral infectivity

E. Zoratti, M. Scupoli, A. Siccardi, 2017, Scientific Reports.

Is Cross-Reactive Immunity Triggering COVID-19 Immunopathogenesis?

D. Zipeto, A. Beretta, M. Cranage, 2020, Frontiers in Immunology.

Cross-reactive response to human immunodeficiency virus type 1 (HIV-1) gp120 and HLA class I heavy chains induced by receipt of HIV-1-derived envelope vaccines.

L. Lopalco, N. Roberts, R. Longhi, 1993, The Journal of infectious diseases.

Autoantibodies against beta 2-microglobulin-free HLA antigens in AIDS patients.

L. Lopalco, A. Lazzarin, P. Meroni, 1993, Journal of acquired immune deficiency syndromes.

Disorders of candidacidal activity and other neutrophil functions in three cases of chronic candidiasis.

M. Cisternino, A. Siccardi, A. Beretta, 1979, Helvetica paediatrica acta.

High incidence and heterogeneity of functional defects of the alternative pathway of complement among atopic children.

A. Ugazio, A. Giannetti, A. Siccardi, 1980, Journal of clinical & laboratory immunology.

A simplified flow cytometry method of CD4 and CD8 cell counting based on thermoresistant reagents: Implications for large scale monitoring of HIV‐infected patients in resource‐limited settings

B. Autran, A. Lazzarin, V. Colizzi, 2005, Cytometry. Part B, Clinical cytometry.

Expression of distinct conformations of free HLA-Cw4 heavy chains in transfected neuroblastoma cells

R. Meneveri, A. Siccardi, A. Beretta, 2006, Immunogenetics.

Selected Pool of Peptides from ESAT-6 and CFP-10 Proteins for Detection of Mycobacterium tuberculosis Infection

Paolo Scarpellini, Silvana Tasca, Laura Galli, 2004, Journal of Clinical Microbiology.

Dextran Sulphate Selectively Enhances Interleukin‐2‐Dependent Cytotoxic T Lymphocyte Growth but Not Differentiation

D. Primi, A. Beretta, 1984, Scandinavian journal of immunology.

Anti-cell antibodies in exposed seronegative individuals with HIV type 1-neutralizing activity.

L. Lopalco, A. Lazzarin, S. Burastero, 2000, AIDS research and human retroviruses.

Clonal specificity of concanavalin A‐induced cytotoxic T lymphocytes

E. Larsson, A. Beretta, Myriam Ermonval, 1985, European journal of immunology.

The Appealing Story of HIV Entry Inhibitors

A. Lazzarin, P. Biswas, A. Castagna, 2012, Drugs.

A case of HIV-associated fever of unknown origin: deficit of IL-1beta antagonistic activity and resolution with monocyte-granulocyte apheresis.

A. Lazzarin, P. Biswas, S. Nozza, 2006, AIDS.

Efficacy of a Standardized Extract of Prunus mume in Liver Protection and Redox Homeostasis: A Randomized, Double‐Blind, Placebo‐Controlled Study

J. Cardot, A. Beretta, R. Accinni, 2016, Phytotherapy research : PTR.

Antioxidant Activity with Increased Endogenous Levels of Vitamin C, E and A Following Dietary Supplementation with a Combination of Glutathione and Resveratrol Precursors

S. Mrakic-Sposta, A. Vezzoli, M. Malnati, 2020, Nutrients.

Favorable outcome of ex‐vivo purging of monocytes after the reintroduction of treatment after interruption in patients infected with multidrug resistant HIV‐1

A. Lazzarin, M. Clerici, M. Cernuschi, 2007, Journal of medical virology.

A cell line-based bioassay of non β-chemokine-related HIV suppressive activity

J. Braun, A. Beretta, 2000 .

Heterogeneity in exposed uninfected individuals.

L. Lopalco, A. Lazzarin, S. Burastero, 1997, Journal of biological regulators and homeostatic agents.

Autoantibodies to CD4 in HIV type 1-exposed seronegative individuals.

L. Lopalco, A. Lazzarin, F. Celada, 1996, AIDS research and human retroviruses.

Nuclear levels of NF‐κB correlate with syncytium‐forming capacity of 8e51 cells, expressing a defective HIV virus

L. Guerrini, F. Blasi, A. Beretta, 1997, FEBS letters.

Identification of human immunodeficiency virus type 1 glycoprotein gp120/gp41 interacting sites by the idiotypic mimicry of two monoclonal antibodies.

L. Lopalco, J. Moore, R. Longhi, 1993, AIDS research and human retroviruses.

Comment on “Influence of HLA-C Expression Level on HIV Control”

P. Giacomini, P. Biswas, D. Zipeto, 2013, Science.

Selective granulocyte/monocyte apheresis in the treatment of HIV-infected patients: short-term and long-term effects on immunological and virological parameters

Mario Clerici, Adriano Lazzarin, Massimo Alfano, 2002, Perfusion.

Effector functions and specificities of normal murine T cells stimulated by syngeneic blasts

A. Coutinho, M. Gullberg, A. Beretta, 1986, European journal of immunology.

Unexpected liaisons between old cytokines and new deadly virus.

A. Beretta, 2020, Swiss medical weekly.

Correction for Parolini et al., “Stability and Expression Levels of HLA-C on the Cell Membrane Modulate HIV-1 Infectivity”

M. Scupoli, R. Biassoni, M. Romanelli, 2018, Journal of Virology.

Reduced expression of major histocompatibility complex class I free heavy chains and enhanced sensitivity to natural killer cells after incubation of human lymphoid lines with β2‐microglobulin

E. Klein, A. Siccardi, E. Carbone, 1993, European journal of immunology.

Granulocyte/monocyte apheresis induces sustained increases in CD4 T cells in HIV-1 infected patients with poor CD4 T cell restoration after suppression of viral replication by HAART.

M Alfano, A. Lazzarin, M. Clerici, 2002, Journal of biological regulators and homeostatic agents.

Immunovirological improvement in partially HAART responder HIV‐infected patients by monocyte adsorption apheresis

A. Lazzarin, M. Clerici, P. Ferrante, 2001, Journal of clinical apheresis.

Membrane expression of HLA-Cw4 free chains in activated T cells of transgenic mice

A. Fattorossi, A. Siccardi, A. Aiuti, 2004, Immunogenetics.

Detection of Cell‐Mediated Lympholysis Determinants Encoded by the I‐A and I‐E Genes on Ultraviolet‐Irradiated Spleen Cells

E. Larsson, A. Beretta, 1985, Scandinavian journal of immunology.